Search by CAS No , Chemical Name or Molecular Formula
Long Term Storage
"Ketorolac, sold under the brand name Toradol among others, is a non-steroidal anti-inflammatory drug (NSAID) in the family of heterocyclic acetic acid derivatives, used as an analgesic. It is considered a first-generation NSAID. An eye drop is available and is used to treat eye pain.
Ketorolac acts by inhibiting the bodily synthesis of prostaglandins. Ketorolac in its oral (tablet or capsule) and intramuscular (injected) preparations is a racemic mixture of both (S)-(\u2212)-ketorolac, the active isomer, and (R)-(+)-ketorolac.
Ketorolac was developed in 1989 by Syntex Corp. (now part of Roche). It was approved for medical use in the United States in 1989. The eye-drop form was approved by FDA in 1992. An intranasal formulation was approved by FDA in 2010 for short-term management of moderate to moderately severe pain requiring analgesia at the opioid level. As of 2015, the cost for a typical course of medication in the United States is less than US$25.",""
Ketorolac is a pyrrolizine carboxylic acid derivative structurally related to INDOMETHACIN. It is an NSAID and is used principally for its analgesic activity.
Fundinguniverse.com. Retrieved 2013-10-06; Lee, I. O.; Seo, Y. (2008)
We normally respond within 8 hours.
This page contains information about Ketorolac Cas # 74103-06-3 and its API Standards.
Ketorolac Ketorolac Worldwide Suppliers of Ketorolac https://www.clearsynth.com/en/CSO01709.html API Standards Clearsynth 74103-06-3
Product rating: 9 Ketorolac based on 20 ratings
Keywords: API Standards 5-benzoyl-2,3-dihydro-1H-pyrrolizine-1carboxylc cid CS-O-01709 Ketorolac Ketorolac 74103-06-3 255.27 C15H13NO3
Internal standard, Internal standard Ketorolac, HPLC-MS method validation, HPLC-MS method validation Ketorolac, LC-MS-MS method validation, LC-MS-MS method validation Ketorolac, Deuterated internal standard, Deuterated internal standard Ketorolac, Deuterated Ketorolac, Deuterium labeled Ketorolac, Quantitative bioanalytical methods, Quantitative bioanalytical methods Ketorolac, Blood samples Ketorolac, Blood concentrations, Heavy drugs, Analysis, Analysis Ketorolac, Clinical diagnostic, Clinical diagnostic Ketorolac, Dosing Ketorolac, Analytical method development, Internal standard method.
CLEARSYNTH CANADA INC.
2395 Speakman Drive,
Lab: 1001, Mississauga, ON,
Canada L5K 1B3
T : +1-289-729-0060
CLEARSYNTH RESEARCH CENTRE
Plot No. 177, IDA, Mallapur,
T : +91-40-27155481
CLEARSYNTH LABS LTD
17, Lotus Business Park,
Andheri (W), Mumbai - 400053
T : +91-22-45045945